Onder Alpdogan Selected Research

Onder Alpdogan Research Topics

Disease

21	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2020 - 12/2002
13	Neoplasms (Cancer) 01/2022 - 12/2002
6	Mycosis Fungoides 07/2020 - 03/2015
5	Lymphoma (Lymphomas) 10/2022 - 09/2004
4	Infections 09/2006 - 06/2003
2	HIV Infections (HIV Infection) 01/2021 - 03/2019
2	Leukemia 01/2005 - 03/2003
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 10/2022
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 10/2022
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 02/2019
1	Disease Progression 02/2019
1	Pericardial Effusion 05/2017
1	Multiple Myeloma 05/2017
1	Plasmacytoma 05/2017
1	Hypersensitivity (Allergy) 07/2016
1	Subcutaneous panniculitis-like T-cell lymphoma 06/2015
1	T-Cell Lymphoma (Lymphoma, T Cell) 06/2015
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2014
1	Hematologic Diseases (Blood Diseases) 01/2011
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2011
1	Inflammation (Inflammations) 01/2011
1	Renal Cell Carcinoma (Grawitz Tumor) 08/2007
1	Atrophy 06/2007
1	Experimental Melanoma 09/2006
1	Autoimmune Diseases (Autoimmune Disease) 01/2005
1	Mesothelioma 12/2004
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2004
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 09/2004
1	Thrombocytosis (Thrombocythemia) 03/2004

Drug/Important Bio-Agent (IBA)

4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2009 - 12/2002
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2022 - 10/2020
2	Methotrexate (Mexate)FDA LinkGeneric 03/2019 - 09/2004
2	Interleukin-15 (Interleukin 15)IBA 07/2017 - 01/2005
2	DNA (Deoxyribonucleic Acid)IBA 02/2009 - 09/2006
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2022
1	Prednisone (Sone)FDA LinkGeneric 10/2022
1	Vincristine (Oncovin)FDA LinkGeneric 10/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	Complement System Proteins (Complement)IBA 02/2019
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2019
1	Amlodipine (Norvasc)FDA LinkGeneric 07/2016
1	Rituximab (Mabthera)FDA Link 11/2014
1	Calcineurin InhibitorsIBA 03/2013
1	MTOR InhibitorsIBA 03/2013
1	Glycoproteins (Glycoprotein)IBA 01/2011
1	CEACAM1 ProteinIBA 01/2011
1	P-SelectinIBA 08/2010
1	Interferon-gamma (Interferon, gamma)IBA 02/2009
1	Fas Ligand Protein (Fas Ligand)IBA 08/2007
1	SteroidsIBA 06/2007
1	DNA VaccinesIBA 09/2006
1	AntigensIBA 09/2006
1	integrin beta7IBA 02/2006
1	Proteins (Proteins, Gene)FDA Link 12/2004
1	Folic Acid AntagonistsIBA 12/2004
1	Cisplatin (Platino)FDA LinkGeneric 12/2004
1	Pemetrexed (MTA)FDA Link 12/2004
1	Cytidine DeaminaseIBA 09/2004
1	Cytarabine (Cytosar-U)FDA LinkGeneric 09/2004
1	Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA 09/2004
1	Complementary DNA (cDNA)IBA 03/2004
1	integrin alpha4beta7IBA 02/2004
1	IntegrinsIBA 02/2004
1	Interleukin-7 (Interleukin 7)IBA 10/2003
1	Insulin-Like Growth Factor I (IGF-1)IBA 06/2003
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 03/2003
1	AntibodiesIBA 03/2003
1	TNF-Related Apoptosis-Inducing LigandIBA 12/2002

Therapy/Procedure

10	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2011 - 03/2003
9	Hematopoietic Stem Cell Transplantation 10/2020 - 11/2005
7	Therapeutics 10/2022 - 01/2005
4	Stem Cell Transplantation 01/2022 - 09/2006
3	Drug Therapy (Chemotherapy) 05/2017 - 09/2004
2	Immunotherapy 02/2019 - 11/2014
2	Radiotherapy 03/2015 - 11/2004
2	Cell Transplantation 11/2014 - 12/2002
2	Transplantation 03/2013 - 09/2004
1	Brachytherapy 03/2015
1	Autologous Transplantation 11/2014
1	Hematopoietic Stem Cell Mobilization 03/2004